Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene silencing by methyl-CpG-binding proteins

X Nan1, S Cross, A Bird

  • 1Institute of Cell and Molecular Biology, University of Edinburgh, UK.

Novartis Foundation Symposium
|May 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computed tomography of traumatic abdominal wall hernias: recognition, associated injuries, and impact on management in blunt trauma.

Clinical radiology·2026
Same author

Improving maternity and neonatal care in England: protocol for a formative evaluation of the implementation of the core competency framework to enhance multi-professional practice.

BMC pregnancy and childbirth·2026
Same author

Provenance of late Pleistocene loess in central and eastern Europe: isotopic evidence for dominant local sediment sources.

Scientific reports·2025
Same author

Volatile capture technology in sustainable anaesthetic practice: a narrative review.

Anaesthesia·2024
Same author

A radiologist's guide to median sternotomy.

Clinical radiology·2023
Same author

Inulin-induced differences on serum extracellular vesicles derived miRNAs in dairy cows suffering from subclinical mastitis.

Animal : an international journal of animal bioscience·2023
Same journal

Genetic and therapeutic control of diabetogenic CD8+ T cells.

Novartis Foundation symposium·2009
Same journal

Translating mucosal antigen based prevention of autoimmune diabetes to human.

Novartis Foundation symposium·2009
Same journal

Re-establishing immune tolerance in type 1 diabetes via regulatory T cells.

Novartis Foundation symposium·2009
Same journal

Immune markers of disease and therapeutic intervention in type 1 diabetes.

Novartis Foundation symposium·2009
Same journal

Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass.

Novartis Foundation symposium·2009
Same journal

CD8 and cytotoxic T cells in type 1 diabetes.

Novartis Foundation symposium·2009
See all related articles

CpG methylation silences genes by recruiting repressors like methyl-CpG-binding protein 2 (MeCP2). MeCP2 is a potent, widespread transcriptional repressor dependent on methylated DNA for its function.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Gene Regulation

Background:

  • CpG methylation is a key epigenetic mechanism influencing gene expression.
  • Methylation can interfere with transcription factor binding, leading to gene silencing.
  • Repressor proteins binding to methylated CpG sites are major mediators of silencing.

Purpose of the Study:

  • To investigate the roles of methyl-CpG-binding proteins in gene silencing.
  • To characterize methyl-CpG-binding protein 1 (MeCP1) and methyl-CpG-binding protein 2 (MeCP2).

Main Methods:

  • Studied the binding properties and functions of MeCP1 and MeCP2.
  • Assessed the localization and transcriptional repressor activity of MeCP2.
  • Reviewed existing literature and recent findings on MeCP1.

Related Experiment Videos

Main Results:

  • MeCP2 is an abundant chromosomal protein localized to the nucleus based on CpG methylation.
  • MeCP2 functions as a potent transcriptional repressor with a genome-wide distribution.
  • MeCP1 requires multiple methylated CpGs for binding and is implicated in transcriptional repression.

Conclusions:

  • MeCP2 is a significant mediator of CpG methylation-induced gene silencing.
  • MeCP1 also plays a role in transcriptional repression dependent on methylated CpG sites.
  • Further research into MeCP1 components may elucidate its precise mechanism of action.